Medical diagnostic company Myconostica has announced the CE marking of its Mycassay Aspergillus and Mycassay Pneumocystis on the Roche Lightcycler 2.0 and Stratagene Mx3000 series platforms.
The CE marking on these platforms in addition to the existing CE marking on the Cepheid Smartcycler and the Applied Biosystems ABI 7500 means these products are now available on the four real-time PCR machines most common in clinical microbiology and mycology laboratories.
Mycassay Pneumocystis is a molecular diagnostic test for the detection of Pneumocystis jirovecii DNA in lower respiratory tract samples.
The kit is designed to be used by qualified laboratory professionals, and the results are said to aid physicians in making a diagnosis in patients suspected of having an infection caused by Pneumocystis jirovecii.
Mycassay Aspergillus is a molecular diagnostic test for the detection of Aspergillus spp DNA in lower respiratory tract samples.
This kit is also designed to be used by qualified laboratory professionals, and the results can aid physicians to make a diagnosis in patients suspected of having an infection caused by Aspergillus.
When used in conjunction with Myconostica's fungal DNA extraction system - Mycxtra - a result can be obtained within three hours of sample receipt.
